AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38

Authors: CUTULI B PETIT T HOFFSTETTER S VELTEN M DUFOUR P GIRON C LEDERLIN P JUNG GM BERGERAT JP MALOISEL F BEY P OBERLING F
Citation: B. Cutuli et al., TREATMENT OF SUBDIAPHRAGMATIC HODGKINS-DISEASE - LONG-TERM RESULTS AND SIDE-EFFECTS, Oncology Reports, 5(6), 1998, pp. 1513-1518

Authors: KURTZ JE DEPLANQUE G DUCLOS B EICHLER F GIRON C LIMACHER JM HERBRECHT R MALOISEL F OBERLING F BERGERAT JP DUFOUR P
Citation: Je. Kurtz et al., PACLITAXEL-ANTHRACYCLINE COMBINATION CHEMOTHERAPY IN RELAPSING ADVANCED OVARIAN-CANCER AFTER PLATINUM-BASED CHEMOTHERAPY - A PILOT-STUDY, Gynecologic oncology (Print), 70(3), 1998, pp. 414-417

Authors: CERALINE J DEPLANQUE G DUCLOS B LIMACHER JM HAJRI A NOEL F ORVAIN C FREBOURG T KLEINSOYER C BERGERAT JP
Citation: J. Ceraline et al., INACTIVATION OF P53 IN NORMAL HUMAN-CELLS INCREASES G(2) M ARREST ANDSENSITIVITY TO DNA-DAMAGING AGENTS/, International journal of cancer, 75(3), 1998, pp. 432-438

Authors: MASSARD G EICHLER F GASSER B BERGERAT JP WIHLM JM
Citation: G. Massard et al., RECURRENCE OF THE MEDIASTINAL GROWING TERATOMA SYNDROME, The Annals of thoracic surgery, 66(2), 1998, pp. 605-606

Authors: GURIEC N GAIRARD B MARCELLIN L CALDEROLI H RENAUD R WILK A BERGERAT JP OBERLING F
Citation: N. Guriec et al., ARE CD44 SPLICED VARIANTS INVOLVED IN HUMAN BREAST-CANCER METASTASIS (REVIEW), Oncology Reports, 4(4), 1997, pp. 769-774

Authors: GURIEC N GAIRARD B MARCELLIN L WILK A CALDEROLI H RENAUD R BERGERAT JP OBERLING F
Citation: N. Guriec et al., EXPRESSION OF CD44 SPLICED VARIANTS WITH BOTH EXONS V9 AND V10 IN PRIMARY N(-)M(-) BREAST CARCINOMAS CORRELATES WITH METASTASIS, International journal of oncology, 10(1), 1997, pp. 171-175

Authors: KLEINSOYER C CERALINE J ORVAIN C DELASALLE C BERGERAT JP CAZENAVE JP
Citation: C. Kleinsoyer et al., ANGIOGENESIS INHIBITOR SR-25989 UP-REGULATES THROMBOSPONDIN-1 EXPRESSION IN HUMAN VASCULAR ENDOTHELIAL-CELLS AND FORESKIN FIBROBLASTS, Biology of the cell, 89(4), 1997, pp. 295-307

Authors: GURIEC N GAIRARD B MARCELLIN L WILK A CALDEROLI H RENAUD R BERGERAT JP OBERLING F
Citation: N. Guriec et al., CD44 ISOFORMS WITH EXON V6 AND METASTASIS OF PRIMARY N0M0 BREAST CARCINOMAS, Breast cancer research and treatment, 44(3), 1997, pp. 261-268

Authors: TEH BT GIRAUD S SARI NF HII SI BERGERAT JP LARSSON C LIMACHER JM NICOL D
Citation: Bt. Teh et al., FAMILIAL NON-VHL NON-PAPILLARY CLEAR-CELL RENAL-CANCER, Lancet, 349(9055), 1997, pp. 848-849

Authors: WIHLM J LIMACHER JM LEVEQUE D DUCLOS B BERGERAT JP METHLIN G
Citation: J. Wihlm et al., PHARMACOKINETICS OF HIGH-DOSE DOXORUBICIN ADMINISTERED AS A 6-H INTRAVENOUS-INFUSION IN BREAST-CANCER PATIENTS, Bulletin du cancer, 84(6), 1997, pp. 603-608

Authors: EICHLER F ACHOUR NE VETTER JM BERGERAT JP JACQMIN D
Citation: F. Eichler et al., NEURECTODERMAL DIFFERENTIATION OF AN EMBR YONAL CARCINOMA OF THE TESTIS, Bulletin du cancer, 84(6), 1997, pp. 630-633

Authors: CERALINE J DEPLANQUE G DUCLOS B LIMACHER JM VINCENT F GOLDBLUM S BERGERAT JP
Citation: J. Ceraline et al., RELATIONSHIPS BETWEEN P53 INDUCTION, CELL -CYCLE ARREST AND SURVIVAL OF NORMAL HUMAN FIBROBLASTS FOLLOWING DNA-DAMAGE, Bulletin du cancer, 84(11), 1997, pp. 1007-1016

Authors: DUFOUR P MORS R BERTHAUD P LAMY T BERGERAT JP HERBRECHT R MALOISEL F AUDHUY B LIOURE B GIRON C HURTELOUP P OBERLING F
Citation: P. Dufour et al., IDARUBICIN AND HIGH-DOSE CYTARABINE - A NEW SALVAGE TREATMENT FOR REFRACTORY OR RELAPSING NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 22(3-4), 1996, pp. 329-334

Authors: DUFOUR P HUSSEINI F DREYFUS B CURE H MARTIN C PREVOST G OLIVIER JP DUMAS F DUCLOS B OLIVARES R LESZLER A BERGERAT JP AUDHUY B THILL L OBERLING F
Citation: P. Dufour et al., 5-FLUOROURACIL VERSUS 5-FLUOROURACIL PLUS ALPHA-INTERFERON AS TREATMENT OF METASTATIC COLORECTAL-CARCINOMA - A RANDOMIZED STUDY, Annals of oncology, 7(6), 1996, pp. 575-579

Authors: GURIEC N MARCELLIN L GAIRARD B CALDEROLI H WILK A RENAUD R BERGERAT JP OBERLING F
Citation: N. Guriec et al., CD44 EXON-6 EXPRESSION AS A POSSIBLE EARLY PROGNOSTIC FACTOR IN PRIMARY NODE-NEGATIVE BREAST-CARCINOMA, Clinical & experimental metastasis, 14(5), 1996, pp. 434-439

Authors: GURIEC N MARCELLIN L GAIRARD B CALDEROLI H WILK A RENAUD R BERGERAT JP OBERLING F
Citation: N. Guriec et al., E-CADHERIN MESSENGER-RNA EXPRESSION IN BREAST CARCINOMAS CORRELATES WITH OVERALL AND DISEASE-FREE SURVIVAL, Invasion & metastasis, 16(1), 1996, pp. 19-26

Authors: RIEGEL P RUIMY R DEBRIEL D EICHLER F BERGERAT JP CHRISTEN R MONTEIL H
Citation: P. Riegel et al., BACTEREMIA DUE TO GORDONA-SPUTI IN AN IMMUNOCOMPROMISED PATIENT, Journal of clinical microbiology, 34(8), 1996, pp. 2045-2047

Authors: RIEGEL P RUIMY R DEBRIEL D EICHLER F BERGERAT JP CHRISTEN R MONTEIL H
Citation: P. Riegel et al., BACTEREMIA DUE TO GORDONA-SPUTI IN AN IMMUNOCOMPROMISED PATIENT (VOL 34, PG 2046, 1996), Journal of clinical microbiology, 34(12), 1996, pp. 3258-3258

Authors: PETIT T DUFOUR P BARRATS JC MALOISEL F DUCLOS B GIRON C LIOURE B DELLENBACH P RENAUD R RITTER J AUDHUY B BERGERAT JP OBERLING F
Citation: T. Petit et al., CARBOPLATIN-CYCLOPHOSPHAMIDE IN STAGE IC- IV OVARIAN-CARCINOMA - A RETROSPECTIVE STUDY OF 101 CASES, Bulletin du cancer, 83(7), 1996, pp. 566-572

Authors: DUFOUR P HAMID D BARATS JC DUCLOS B LIOURE B BERGERAT JP OBERLING F
Citation: P. Dufour et al., PROGNOSTIC FACTORS IN OVARIAN-CARCINOMA IN PATHOLOGICAL COMPLETE REMISSION (PCR) AT 2ND-LOOK SURGERY (SL), European journal of cancer, 31A, 1995, pp. 499-499

Authors: LIMACHER JM DUCLOS B WIHLM J LEVEQUE D DUFOUR P EICHLER F KEILING R BERGERAT JP
Citation: Jm. Limacher et al., PHASE-I STUDY OF HIGH-DOSE 5-FLUOROURACIL AND FOLINIC ACID IN WEEKLY CONTINUOUS-INFUSION, European journal of cancer, 31A, 1995, pp. 945-945

Authors: FAUSER AA BERGERAT JP COCQUYT V CHEMAISSANI A DELFAVERO A DRESSLER HT
Citation: Aa. Fauser et al., DOUBLE-BLIND, COMPARATIVE TRIAL OF 4 SINGLE ORAL DOSES OF DOLASETRON MESILATE (DM) AND MULTIPLE DOSES OF ONDANSETRON (OND) FOR EMESIS PREVENTION AFTER MODERATELY EMETOGENIC CHEMOTHERAPY (CT), European journal of cancer, 31A, 1995, pp. 1217-1217

Authors: MARTY M KLEISBAUER JP FOURNEL P VERGNENEGRE A CARLES P LORIAKANZA Y SIMONETTA C DEBRUIJN KM LAURAINE P DIDIER A CUPISSOL D BERGERAT JP PUJAZON MC HERON JF DRENO B TAYTARD A GUERIN JC CLAVIER J ROBINET G BLANCHON F BALMES P MUIR JF PAILLOTIN D POIRIER R BONNETERRE J MELLONI B ROCHE H DEPIERRE A PLAGNE R SOUQUET PJ ARMAND JP DEFORNI M
Citation: M. Marty et al., IS NAVOBAN(R) (TROPISETRON) AS EFFECTIVE AS ZOFRAN(R) (ONDANSETRON) IN CISPLATIN-INDUCED EMESIS, Anti-cancer drugs, 6, 1995, pp. 15-21

Authors: WAJCMAN H GIRODON E PROME D NORTH ML PLASSA F DUWIG I KISTER J BERGERAT JP OBERLING F LAMPERT E LONSDORFER J GOOSSENS M GALACTEROS F
Citation: H. Wajcman et al., GERMLINE MOSAICISM FOR AN ALANINE TO VALINE SUBSTITUTION AT RESIDUE-BETA-140 IN HEMOGLOBIN PUTTELANGE, A NEW VARIANT WITH HIGH OXYGEN-AFFINITY, Human genetics, 96(6), 1995, pp. 711-716

Authors: LIU KL HERBRECHT R LIOURE B JAULHAC B MALOISEL F DUFOUR P BERGERAT JP OBERLING F
Citation: Kl. Liu et al., EFFECTS OF BACTERIAL NASO-OROPHARYNGEAL COLONIZATION ON ACUTE GRAFT-VERSUS-HOST DISEASE IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 15(1), 1995, pp. 65-69
Risultati: 1-25 | 26-38